Gyros Protein Technologies
Monmouth Junction
About Gyros Protein Technologies
Gyros is the world leader in automated micro-immunoassays for therapeutic protein development. Gyrolab, the company's automated and open platform, is a versatile analytical tool that dramatically reduces the time required to optimize and execute immunoassays. Time for assay optimization is often cut from weeks, to a matter of days. This results in increased efficiency in process development and in clinical evaluation of therapeutic proteins. The ease of assay transfer is unsurpassed in the industry.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $39.9M
- Funding stage: Late Stage Venture
- Last round: Series C (Jul 2009)
- Website: gyros.com
- Phone: (461)856-6300
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/gyros-protein-technologies-432813 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.